G.I.T. Laboratory Journal Europe
G.I.T. business web at www.laboratory-journal.com
G.I.T. Laboratory Journal Europe consists of three parts.
- In the “Research and Development” section we publish up-to-date scientific research articles from highly reputated authors
- The “Screening inside” section reports on recent developments in the drug discovery and pharmaceutical industry,contract research and clinical testing
- The “Technology & Instrumentation” section reports on new developments in laboratory instrumentation and application
Reflecting the increasing overlap of the chemistry and biology business and academia we strongly increased the editorial coverage on life sciences. Who are the readers of the G.I.T. Laboratory Journal Europe? G.I.T. Laboratory Journal Europe is published bimonthly and reaches 27.000 personalized addressees in industrial R&D and scientific institutions throughout Europe. Decision makers from R&D departments of universities, chemical, pharmaceutical and biotechnological corporations rely on the articles and news provided by the G.I.T. Laboratory Journal Europe. Our readership spread all across Europe; the G.I.T. Laboratory Journal Europe is read mainly the UK, Germany, Switzerland, Austria, Scandinavia and the Netherlands.
With our online-portal www.laboratory-journal.com we guarantee a global reach.
We bring together what belongs together
Highest scientific quality framed by an elaborated layout defines the environment in which we embed advertisements. We refined our portfolio to ensure that your articles and advertisement reach the targeted audience with a single publication. We merged BIOforum Europe and G.I.T. Laboratory Journal Europe because we realized that the same already happened in business and academia.
We integrated Screening –Trends in Drug Discovery as “Screening inside” because laboratory automation and systematic drug screening are an integral part of the life science business.